MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Life Sciences, Medical Devices & Health Information Technology
2025: Top 10 U.S. Biopharma Clusters 2025
New Jersey
*Industry: New Jersey
TyRx Pharma, Inc.-CeMBR
Organization & Developments: TyRx
Parents
TyRx Pharma, Inc.-CeMBR
Children
90 day FDA clearance process
Based on the systematic generation and characterization of libraries of materials created using the techniques of combinatorial
Comprehensive patent portfolio and patent applications covering tyrosine-based resorbable polymer systems
Designing, developing, and commercializing next-generation resorbable polymeric biomaterials
Partially degradable hernia repair device
Tyrosine-based resorbable polymer systems have been created for use in drug delivery and medical device applications.
TyRx holds an exclusive worldwide license from Rutgers, the State University of New Jersey,
TyRx is dedicated to the innovation, development and commercialization of high-value combination medical devices and pharmaceutical products, utilizing robust tyrosine-based resorbable polymer systems in collaboration with world-class partners.
TYRX, Inc., the leader in the commercialization of implantable medical devices designed to help reduce surgical-site infections associated with implantable pacemakers and defibrillators
Jumps
*Key People: TyRx
Finance & Acquisitions: TyRx